Data / Form D filings / Vizgen, Inc.
Vizgen, Inc.: Form D filings
Vizgen, Inc., a biotechnology company in Waltham, MA, filed 6 Form D notices with the SEC between 2019 and 2026. The latest, on January 12, 2026, reports $47.8 million sold of a $50 million offering to 9 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 150 Bear Hill Road, Waltham, MA, 02451
- Phone
- (833) 222-8206
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1790415
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | New notice | $50,000,000 | $47,788,714 | $2,211,286 | 9 | Dec 29, 2025 | sec.gov |
| Oct 7, 2025 | New notice | $9,500,000 | $3,500,000 | $6,000,000 | 7 | Oct 1, 2025 | sec.gov |
| Oct 22, 2024 | New notice | Indefinite | $107,575,628 | 61 | Oct 8, 2024 | sec.gov | |
| May 5, 2022 | New notice | $105,199,991 | $85,199,997 | $19,999,994 | 15 | Apr 21, 2022 | sec.gov |
| Apr 8, 2021 | New notice | $36,999,998 | $36,999,998 | 12 | Mar 26, 2021 | sec.gov | |
| Oct 15, 2019 | New notice | $13,999,997 | $13,999,997 | 3 | Oct 1, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Robert Carson | Executive Officer, Director | |
| Simona Levi | Executive Officer | |
| Matthew Posard | Director | |
| Keith Crandell | Director | |
| Andrea Jackson | Director | |
| David Walt | Director | |
| Christian Uhrich | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Jan 12, 2026 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Vizgen, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.